Implementing personalized lung cancer care with spatial profiling, patient derived organoids, and rationally designed drug testing. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I ...
Breast Cancer Index re-stratifies 21-gene assay risk groups for late distant recurrence and extended endocrine therapy benefit: Results from the BCI Registry Study. This is an ASCO Meeting Abstract ...